These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6211762)

  • 1. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.
    Varenhorst E; Wallentin L; Carlström K
    Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancer.
    Rost A; Schmidt-Gollwitzer M; Hantelmann W; Brosig W
    Prostate; 1981; 2(3):315-22. PubMed ID: 6458025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of orchidectomy performed after cessation of estrogen therapy on serum testosterone concentrations in patients with prostatic carcinoma.
    Tomić R; Damber JE
    Urol Int; 1987; 42(6):441-4. PubMed ID: 3129850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol ester metabolism in plasma during estrogen and antiandrogen treatment in men with carcinoma of the prostate.
    Wallentin L; Varenhorst E
    J Lab Clin Med; 1981 Dec; 98(6):906-16. PubMed ID: 6458644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
    Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
    Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of cyproterone acetate on the plasma gonadotrophin response to gonadotrophin releasing hormone.
    Donald RA; Espiner EA; Cowles RJ; Fazackerley JE
    Acta Endocrinol (Copenh); 1976 Apr; 81(4):680-4. PubMed ID: 769466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of cyproterone acetate in achieving castration and preventing luteinizing hormone releasing hormone analogue induced testosterone surge in patients with prostate cancer.
    Appu S; Lawrentschuk N; Grills RJ; Neerhut G
    J Urol; 2005 Jul; 174(1):140-2. PubMed ID: 15947599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects.
    Huhtaniemi I; Parvinen M; Venho P; Rannikko S
    Int J Androl; 1991 Oct; 14(5):374-86. PubMed ID: 1839022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
    Bantis A; Zissimopoulos A; Athanasiadou P; Gonidi M; Agelonidou E; Strataki A; Matthaios D; Tsartsarakis A
    Hell J Nucl Med; 2007; 10(1):56-61. PubMed ID: 17450256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oestrogens, orchidectomy and cyproterone acetate on salt and water metabolism in carcinoma of the prostate.
    Varenhorst E; Karlberg BE; Wallentin L; Wranne B
    Eur Urol; 1981; 7(4):231-6. PubMed ID: 6453004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen, orchidectomy, and cyproterone acetate on tissue fibrinolysis in patients with carcinoma of the prostate.
    Varenhorst E; Risberg B
    Invest Urol; 1981 Mar; 18(5):355-7. PubMed ID: 7203959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of serum adrenal androgens in prostatic cancer patients after bilateral orchidectomy or LHRH agonist treatment].
    Oka H; Negoro H; Sugino Y; Iwamura H; Moroi S; Kawakita M
    Hinyokika Kiyo; 2003 Sep; 49(9):521-5. PubMed ID: 14598689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproterone acetate lead-in prevents initial rise of serum testosterone induced by luteinizing hormone-releasing hormone analogs in the treatment of metastatic carcinoma of the prostate.
    Boccon-Gibod L; Laudat MH; Dugue MA; Steg A
    Eur Urol; 1986; 12(6):400-2. PubMed ID: 2949980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine effects of cyproterone acetate in patients with prostatic cancer.
    Isurugi K; Fukutani K; Ishida H; Hosoi Y
    J Urol; 1980 Feb; 123(2):180-3. PubMed ID: 7354512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
    Salva P; Morer F; Ordoñez J; Rodriguez J
    Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
    Kobayashi T; Nishizawa K; Mitsumori K
    Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol.
    Kuttenn F; Rigaud C; Wright F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1107-11. PubMed ID: 6448264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
    Hayashi T; Taki Y; Ikai K; Hiura M; Kiriyama T
    Hinyokika Kiyo; 1987 Jul; 33(7):1035-42. PubMed ID: 2446483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.